View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
ANDROMEDA - Daratumumab 1800, maintenance after Dexamethasone (20/20/40) / Cyclophosphamide 300 / Daratumumab 1800 / Bortezomib 1.3 - Daratumumab 1800 maintenance, AL-Amyloidosis, cycle 7+
Protocol-ID: 1633 V1.1 (Mini), ANDROMEDA - DEXA(20/20/40)/CYCL300/DRTM1800/BORT1.3 - DRTM1800 maint., AL-Amyloidosis, C7+Indication(s)
- Amyloidosis; ICD-10 E85.-
AL Amyloidosis
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 11.03.2026